2005
DOI: 10.1016/j.yebeh.2005.03.018
|View full text |Cite
|
Sign up to set email alerts
|

The Brief Symptom Inventory (BSI) as a screening tool for psychological disorders in patients with epilepsy and mild intellectual disabilities in residential care

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
10
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(11 citation statements)
references
References 30 publications
1
10
0
Order By: Relevance
“…1999; Kellett et al . 2003; Endermann 2005; De Beurs & Zitman 2006). Another advantage is that it can be applied across different therapeutic interventions (e.g.…”
Section: Discussionmentioning
confidence: 99%
“…1999; Kellett et al . 2003; Endermann 2005; De Beurs & Zitman 2006). Another advantage is that it can be applied across different therapeutic interventions (e.g.…”
Section: Discussionmentioning
confidence: 99%
“…According to Derogatis, the BSI instrument has good internal reliability with an average rating above 0.7 for the scales. The BSI has good psychometric properties . The scale was previously validated to the Portuguese population by Canavarro, equally showing good psychometric properties.…”
Section: Methodsmentioning
confidence: 99%
“…The BSI has good psychometric properties. 17,18 The scale was previously validated to the Portuguese population by Canavarro, 19 The BI 21 is widely used to assess the degree of dependence (functional status) in the activities of daily living. It enables to measure the level of dependence in the basic daily life activities and is an instrument frequently used in clinical practice and research.…”
Section: Research Tools-brief Descriptionmentioning
confidence: 99%
“…This case rule was originally developed for the SCL-90-R and subsequently recommended for the BSI and BSI-18, though the manual does not present any empirical support for the case-rule as applied to the BSI-18. Following common practice for the BSI (e.g., Brown, Whiteley, Harper, Nichols, & Nieves, 2015; Endermann, 2005) users of the BSI-18 in oncology (Merport & Recklitis, 2012; Michel et al, 2010; Zabora et al, 2001; Zeltzer et al, 2009) and other populations (Hart et al, 2014; Hopp, Anderson, Krumholz, Gruber-Baldini, & Shulman, 2012; Mustanski, Garofalo, Herrick, & Donenberg, 2007; Petkus et al, 2010) commonly define overall significant symptoms on the BSI-18 using the GSI scale alone, classifying respondent with GSI t-score ≥ 63 as having clinically significant symptoms. Both the published BSI-18 case-rule criteria (t-score score ≥ 63 on the GSI, or any two of symptom scales) and the conventional case-rule of GSI t-score ≥ 63 were evaluated in this study.…”
Section: Methodsmentioning
confidence: 99%